284 M. Jabari: Radioprotection 2025, 60( 3), 277 – 284 Sandström M, Garske-Román U, Johansson S, Granberg D, Sundin AN. 2018. Freedman Kidney dosimetry during 177Lu-DOTA- TATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance. Acta Oncol 57: 516.
Segars WP, Tsui BM, Cai J, Yin FF, Fung GS, Samei E. 2017. Application of the 4-D XCAT phantoms in biomedical imaging and beyond. IEEE Trans Med Imag 10: 680.
Seregni E, Maccauro M, Chiesa C, Mariani L, Pascali C, Mazzaferro V, De Braud F, Buzzoni R, Milione M, Lorenzoni A, Bogni A. 2014. Treatment with tandem [ 90 Y ] DOTA-TATE and [ 177 Lu ] DOTA-TATE of neuroendocrine tumours refractory to conventional therapy. Eur J Nucl Med Mol Imag 41: 223.
Sowa-Staszczak A, Pach D, Kunikowska J, Krolicki L, Stefanska A, Tomaszuk M, Buziak-Bereza M, Mikolajczak R, Matyja M, Gilis- Januszewska A, Jabrocka-Hybel A. 2011. Efficacy and safety of 90 Y-DOTATATE therapy in neuroendocrine tumours. Endokrynol. Polska 62: 392.
Thiam C, Breton V, Donnarieix D, Habib B, Maigne L. 2008. Validation of a dose deposited by low-energy photons using GATE / GEA NT4. Phys Med Biol 53: 3039.
Veress AI, Segars WP, Tsui BM. 2010. Gullberg Incorporation of a left ventricle finite element model defining infarction into the ICRP imaging phantom. IEEE Trans Med Imag 30: 915.
Villoing D, Marcatili S, Garcia M, Bardiès M. 2017. Internal dosimetry with the Monte Carlo code GATE: validation using the ICRP / ICRU female reference computational model. Phys Med Biol 62: 1885.
Zemczak A, Gut P, Pawlak D, Kołodziej M, Królicki L, Kos-Kudła B, Ruchała M, Kamiński G, Kunikowska J. 2021. The safety and efficacy of the repeated PRRT with [ 90Y ] Y /[ 177Lu ] Lu-DOTATATE in patients with NET. Int J Endocrinol 23: 2021.
Zweit J. 1996. Radionuclides and carrier molecules for therapy. Phys Med Biol 41: 1905.
Cite this article as: Jabari M. 2025. Size-dependent dose estimation applied to 177 Lu and 90 Y-DOTATATE using ICRP Phantoms. Radioprotection 60( 3): 277 – 284. https:// doi. org / 10.1051 / radiopro / 2025005
Please help to maintain this journal in open access!
This journal is currently published in open access under the Subscribe to Open model( S2O). We are thankful to our subscribers and supporters for making it possible to publish this journal in open access in the current year, free of charge for authors and readers.
Check with your library that it subscribes to the journal, or consider making a personal donation to the S2O programme by contacting subscribers @ edpsciences. org.
More information, including a list of supporters and financial transparency reports, is available at https:// edpsciences. org / en / subscribe-to-open-s2o.